Call For Papers
The ISOIB aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.
The conference highlights advancements in Oncology, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Biomarkers in cancer diagnosis and treatment
- Immunotherapy and its clinical applications
- Role of precision medicine in oncology
- Emerging trends in cancer immunotherapy
- Biomarker discovery and validation
- Challenges in immunotherapy implementation
- Patient selection for immunotherapy
- Combination therapies with immunotherapy
- Ethical issues in biomarker research
- Impact of biomarkers on treatment outcomes
- Innovative technologies in biomarker analysis
- Clinical trials for immunotherapeutic agents
- Role of the immune system in cancer
- Biomarkers for early cancer detection
- Patient perspectives on immunotherapy
- Regulatory considerations for biomarker use
- Future directions in immunotherapy research
- Collaboration between academia and industry
- Health disparities in access to immunotherapy
- Integrating biomarkers into clinical practice
Assessment
Submissions will be assessed for originality, innovation, and relevance. Accepted papers will be presented at the conference and considered for publication opportunities in reputed academic platforms.
Registration
Participants are requested to complete the registration process following acceptance of their paper. Registration ensures inclusion in the conference schedule and official records.
Publication
All accepted manuscripts will be eligible for publication consideration in conference proceedings and associated academic journals.